Measurement of glomerular filtration rate in obese patients: Pitfalls and potential consequences on drug therapy

Obesity Facts

Volumn 4, Issue 3, 2011, Pages 238-243

  Wuerzner, Grégoire ^a   Bochud, Murielle ^b   Giusti, Vittorio ^a   Burnier, Michel ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Institute of Social and Preventive Medicine   (Switzerland)

Author keywords

Glomerular filtration rate; Obesity; Pharmacokinetics

Indexed keywords

CREATININE; CYSTATIN C; INULIN;

BODY SURFACE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOSE RESPONSE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HUMAN; INULIN CLEARANCE; KIDNEY FUNCTION; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

BIOLOGICAL MARKERS; BODY SURFACE AREA; CREATININE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; OBESITY; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 79960192612     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000329547     Document Type: Review

References (51)

1. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-147.
2. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289:76-79. (Pubitemid 36026281)
3. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D: Predictors of new-onset kidney disease in a community-based population. JAMA 2004;291:844-850. (Pubitemid 38543772)
4. Hsu C-Y, Iribarren C, McCulloch CE, Darbinian J, Go AS: Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 2009;169:342-350.
5. Alexander JK, Dennis EW, Smith WG, Amad KH, Duncan WC, Austin RC: Blood volume, cardiac output, and distribution of systemic blood flow in extreme obesity. Cardiovasc Res Cent Bull 1962;1:39-44.
6. Blouin RA, Warren GW: Pharmacokinetic considerations in obesity. J Pharm Sci 1999;88:1-7. (Pubitemid 29037361)
7. Buechler C, Weiss TS: Does hepatic steatosis affect drug metabolizing enzymes in the liver? Curr Drug Metab 2011;12:24-34.
8. Hanley MJ, Abernethy DR, Greenblatt DJ: Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet 2010;49:71-87.
9. Turner ST, Reilly SL: Fallacy of indexing renal and systemic hemodynamic measurements for body surface area. Am J Physiol Regul Integr Comp Physiol 1995;268:R978-988.
10. Delanaye P, Mariat C, Cavalier E, Krzesinski J-M: Errors induced by indexing glomerular filtration rate for body surface area: reductio ad absurdum. Nephrol Dial Transplant 2009;24:3593-3596.
11. Heaf JG: The origin of the 1 × 73-m2 body surface area normalization: problems and implications. Clin Physiol Funct Imaging 2007;27:135-137. (Pubitemid 46605404)
12. Wuerzner G, Pruijm M, Maillard M, Bovet P, Renaud C, Burnier M, Bochud M: Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Am J Kidney Dis 2011;56:303-312.
13. Ribstein J, du Cailar G, Mimran A: Combined renal effects of overweight and hypertension. Hypertension 1995;26:610-615.
14. Anastasio P, Spitali L, Frangiosa A, Molino D, Stellato D, Cirillo E, Pollastro RM, Capodicasa L, Sepe J, Federico P, Gaspare De Santo N: Glomerular filtration rate in severely overweight normotensive humans. Am J Kidney Dis 2000;
15. Peters AM, Glass DM: Use of body surface area for assessing extracellular fluid volume and glomerular filtration rate in obesity. Am J Nephrol 2010;31:209-213.
16. Boer P: Estimated lean body mass as an index for normalization of body fluid volumes in humans. Am J Physiol 1984;247:F632-636. (Pubitemid 15209771)
17. Janmahasatian S, Duffull SB, Chagnac A, Kirkpatrick CM, Green B: Lean body mass normalizes the effect of obesity on renal function. Br J Clin Pharmacol 2008;65:964-965. (Pubitemid 351677429)
18. Morgan DJ, Bray KM: Lean body mass as a predictor of drug dosage. Implications for drug therapy. Clin Pharmacokinet 1994;26:292-307. (Pubitemid 24116207)
19. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310. (Pubitemid 16134762)
20. DuBois M, DuBois E: A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863-871.
21. Mosteller RD: Simplified calculation of body-surface area. N Engl J Med 1987;317:1098.
22. Perrone R, Madias N, Levey A: Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992;38:1933-1953.
23. Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, Hostetter T, Levey AS, Panteghini M, Welch M, Eckfeldt JH: Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006;52:5-18. (Pubitemid 43032461)
24. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
25. Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P: Predictive performance of the modification of diet in renal disease and cockcroft-gault equations for estimating renal function. J Am Soc Nephrol 2005;16:763-773. (Pubitemid 41725113)
26. Verhave JC, Fesler P, Ribstein J, du Cailar G, Mimran A: Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 2005;46:233-241. (Pubitemid 41040351)
27. Dionne RE, Bauer LA, Gibson GA, Griffen WO Jr, Blouin RA: Estimating creatinine clearance in morbidity obese patients. Am J Hosp Pharm 1981;38:841-844.
28. Lim WH, Lim EM, McDonald S: Lean body massadjusted cockcroft and gault formula improves the estimation of glomerular filtration rate in subjects with normal-range serum creatinine. Nephrology (Carlton) 2006;11:250-256. (Pubitemid 43829447)
29. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999; 130:461-470. (Pubitemid 29135798)
30. Manjunath G, Sarnak MJ, Levey AS: Prediction equations to estimate glomerular filtration rate: An update. Curr Opin Nephrol Hypertens 2001;10:785-792. (Pubitemid 33043673)
31. Stevens LA, Coresh J, Feldman HI, Greene T, Lash JP, Nelson RG, Rahman M, Deysher AE, Zhang YL, Schmid CH, Levey AS: Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol 2007;18:2749-2757. (Pubitemid 47531202)
32. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612.
33. 2. Am J Kidney Dis 2010;56:486-495.
34. Salazar DE, Corcoran GB: Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med
35. Spinler S, Nawarskas J, Boyce E, Connors J, Charland S, Goldfarb S: Predictive performance of ten equations for estimating creatinine clearance in cardiac patients. Iohexol cooperative study group. Ann Pharmacother 1998;32:1275-1283. (Pubitemid 29013348)
36. Dharnidharka VR, Kwon C, Stevens G: Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002;40:221-226. (Pubitemid 34827638)
37. Vupputuri S, Fox CS, Coresh J, Woodward M, Muntner P: Differential estimation of CKD using creatinine- versus cystatin C-based estimating equations by category of body mass index. Am J Kidney Dis 2009;53:993-1001.
38. Naour N, Fellahi S, Renucci J-F, Poitou C, Rouault C, Basdevant A, Dutour A, Alessi M-C, Bastard J-P, Clement K, Guerre-Millo M: Potential contribution of adipose tissue to elevated serum cystatin C in human obesity. Obesity 2009;17:2121-2126.
39. Daniel ES, George BC: Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med 1988;84:1053-1060.
40. Korsager S: Administration of gentamicin to obese patients. Int J Clin Pharmacol Ther Toxicol 1980;18:549-553. (Pubitemid 11247535)
41. Sketris I, Lesar T, Zaske DE, Cipolle RJ: Effect of obesity on gentamicin pharmacokinetics. J Clin Pharmacol 1981;21:288-293. (Pubitemid 11013037)
42. Blouin RA, Bauer LA, Miller DD, Record KE, Griffen WO Jr: Vancomycin pharmacokinetics in normal and morbidly obese subjects. Antimicrob Agents Chemother 1982;21:575-580. (Pubitemid 12070524)
43. Vance-Bryan K, Guay DR, Rotschafer JC: Clinical pharmacokinetics of ciprofloxacin. Clin Pharmacokinet 1990;19:434-461.
44. Hollenstein UM, Brunner M, Schmid R, Muller M: Soft tissue concentrations of ciprofloxacin in obese and lean subjects following weight-adjusted dosing. Int J Obes Relat Metab Disord 2001;25:354-358. (Pubitemid 32209810)
45. Sparreboom A, Wolff AC, Mathijssen RH, Chatelut E, Rowinsky EK, Verweij J, Baker SD: Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese. J Clin Oncol 2007;25:4707-4713. (Pubitemid 350086471)
46. O'Dwyer PJ, Stevenson JP, Johnson SW: Clinical pharmacokinetics and administration of established platinum drugs. Drugs 2000;59:19-27. (Pubitemid 30344988)
47. Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, Ernst ND, Horan M: Body mass index and the prevalence of hypertension and dyslipidemia. Obesity 2000;8:605-619.
48. Galletti F, Fasano ML, Ferrara LA, Groppi A, Montagna M, Mancini M: Obesity and beta-blockers: Influence of body fat on their kinetics and cardiovascular effects. J Clin Pharmacol 1989;29:212-216. (Pubitemid 19086823)
49. Cheymol G, Poirier JM, Carrupt PA, Testa B, Weissenburger J, Levron JC, Snoeck E: Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers. Br J Clin Pharmacol 1997;43:563-570. (Pubitemid 27283564)
50. Erstad B: Dosing of medications in morbidly obese patients in the intensive care unit setting. Intensive Care Med 2004;30:18-32. (Pubitemid 38147104)
51. Stevens LA, Levey AS: Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol 2009;20:2305-2313.